- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Esaote posts higher 1998 results
Italian biomedical firm Esaote of Genoa reported 1998 financial results last month, boasting consolidated net sales of $201.2 million, up 25% from 1997's $161.1 million. Esaote's increased net sales include revenues from ultrasound firm Pie Medical,
Italian biomedical firm Esaote of Genoa reported 1998 financial results last month, boasting consolidated net sales of $201.2 million, up 25% from 1997's $161.1 million. Esaote's increased net sales include revenues from ultrasound firm Pie Medical, which Esaote bought from Philips Medical Systems last year (SCAN 4/29/98). Esaote also posted robust international sales of $121.5 million, up 42% from $85.5 million in 1997. The company's international revenues accounted for 60% of its total sales.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
